Search Results

Comparing budesonide treatment in eosinophilic esophagitis: a specialized center cohort versus a population-based cohort.

• Authors : Frandsen LT; Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.; The Faculty of Medicine, Aalborg University, Aalborg, Denmark.

Subjects: Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/drug therapy ; Budesonide*/Budesonide*/Budesonide*/administration & dosage ; Budesonide*/Budesonide*/Budesonide*/therapeutic use

• Source: Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2024 Dec; Vol. 59 (12), pp. 1265-1271. Date of Electronic Publication: 2024 Oct 26.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0060105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Oral viscous budesonide solution for enhanced localized treatment of eosinophilic esophagitis through improved mucoadhesion and permeation.

• Authors : Wu D; National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, China; National Key Laboratory of Lead Druggability Research, China State Institute of Pharmaceutical Industry, Shanghai 201203, China.

Subjects: Budesonide*/Budesonide*/Budesonide*/administration & dosage ; Budesonide*/Budesonide*/Budesonide*/pharmacokinetics ; Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/drug therapy

• Source: Journal of pharmaceutical sciences [J Pharm Sci] 2024 Nov; Vol. 113 (11), pp. 3384-3392. Date of Electronic Publication: 2024 Sep 24.Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Effectiveness of treatment with budesonide orodispersible tablets in 76 patients with eosinophilic oesophagitis - real-life experience from the population-based DanEoE cohort.

• Authors : Frandsen LT; Department of Gastroenterology, North Denmark Regional Hospital, Hjørring, Denmark.; Department of Emergency Medicine and Trauma Center, Aalborg University Hospital, Aalborg, Denmark.

Subjects: Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/drug therapy ; Budesonide*/Budesonide*/Budesonide*/administration & dosage ; Budesonide*/Budesonide*/Budesonide*/therapeutic use

• Source: Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2024 Oct; Vol. 59 (10), pp. 1137-1143. Date of Electronic Publication: 2024 Sep 12.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0060105 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Comparison of budesonide vehicles in inducing histologic remission in pediatric eosinophilic esophagitis.

• Authors : Lendner N; Pediatrix Gastroenterology of the Rocky Mountains, Denver, Colorado, USA.; Minich NM

Subjects: Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/drug therapy ; Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/pathology ; Budesonide*/Budesonide*/Budesonide*/administration & dosage

• Source: Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2024 Jul; Vol. 79 (1), pp. 92-99. Date of Electronic Publication: 2024 May 27.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8211545 Publication Model: Print-Electronic Cited Medium:

Record details

Investigating immune profile by CyTOF in patients with eosinophilic esophagitis after treatment with orodispersible budesonide.

• Authors : Plate J; Department of Otorhinolaryngology Head and Neck Surgery, Region Västra Götaland, NU-Hospital Group, Trollhättan, Sweden.; Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Subjects: Budesonide*/Budesonide*/Budesonide*/therapeutic use ; Budesonide*/Budesonide*/Budesonide*/administration & dosage ; Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/immunology

• Source: Clinical and experimental immunology [Clin Exp Immunol] 2024 Sep 16; Vol. 218 (1), pp. 1-13.Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Budesonide oral suspension (Eohilia) for eosinophilic esophagitis.

Subjects: Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/drug therapy ; Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/diagnosis ; Budesonide*/Budesonide*/Budesonide*/administration & dosage

• Source: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2024 Jun 10; Vol. 66 (1704), pp. 93-95.Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.

• Authors : Laserna-Mendieta EJ; EUREOS and EoE CONNECT research group

Subjects: Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/drug therapy ; Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/diagnosis ; Registries*

• Source: United European gastroenterology journal [United European Gastroenterol J] 2024 Jun; Vol. 12 (5), pp. 585-595. Date of Electronic Publication: 2024 Jan 29.Publisher: Wiley Country of Publication: England NLM ID: 101606807 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2050-6414

Record details

Swallowed topical steroid therapy for eosinophilic oesophagitis in children: practical, evidence-based guidance by the BSPGHAN Eosinophilic Oesophagitis Working Group.

• Authors : Chan J; Paediatric Gastroenterology, University Hospital of Wales, Cardiff, UK.; Flynn DM

Subjects: Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/drug therapy ; Budesonide*/Budesonide*/Budesonide*/administration & dosage ; Budesonide*/Budesonide*/Budesonide*/therapeutic use

• Source: BMJ paediatrics open [BMJ Paediatr Open] 2024 May 23; Vol. 8 (1). Date of Electronic Publication: 2024 May 23.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101715309 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1-3 clinical trials.

• Authors : Hirano I; Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Dellon ES

Subjects: Budesonide* ; Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/drug therapy; Adult

• Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 May; Vol. 57 (10), pp. 1117-1130. Date of Electronic Publication: 2023 Mar 08.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide.

• Authors : Liu X; School of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.; Xiao X

Subjects: Budesonide*/Budesonide*/Budesonide*/adverse effects ; Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/Eosinophilic Esophagitis*/drug therapy; Humans

• Source: Annals of medicine [Ann Med] 2022 Dec; Vol. 54 (1), pp. 2078-2088.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print Cited Medium: Internet ISSN: 1365-2060

Record details